SCHEMBL4784541

SCHEMBL4784541

CC(N)C(=O)N1CCC(c2ccc(C(N)=O)c(C3=CCCCC3)c2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 15/20 0.45
KIT P10721 8/20 0.44
CYP3A4 P08684 6/20 0.43
CYP2C19 P33261 5/20 0.43
NTRK1 P04629 3/20 0.41
LCK P06239 3/20 0.41
AXL P30530 3/20 0.41
FLT3 P36888 3/20 0.41
BMPR1B O00238 2/20 0.41
PLK4 O00444 2/20 0.41
STK25 O00506 2/20 0.41
RIOK3 O14730 2/20 0.41
CHEK1 O14757 2/20 0.41
GAK O14976 2/20 0.41
DCLK1 O15075 2/20 0.41
MUSK O15146 2/20 0.41
EPHB6 O15197 2/20 0.41
PDPK1 O15530 2/20 0.41
MAP3K13 O43283 2/20 0.41
DAPK3 O43293 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2910201 0.88 CSF1R (0.54) CSF1RKITCYP3A4CYP2C19NTRK1
SCHEMBL3075674 0.86 KIT (0.59) CSF1RKITCYP3A4CYP2C19NTRK1
SCHEMBL2915789 0.86 KIT (0.59) CSF1RKITCYP3A4CYP2C19NTRK1
SCHEMBL2912407 0.83 KIT (0.58) CSF1RKITCYP3A4CYP2C19NTRK1
SCHEMBL2912716 0.82 CSF1R (0.43) CSF1RKITCYP3A4CYP2C19NTRK1
SCHEMBL2907515 0.82 CSF1R (0.46) CSF1RKITCYP3A4CYP2C19NTRK1
SCHEMBL2908102 0.82 CSF1R (0.58) CSF1RKITCYP3A4CYP2C19NTRK1
SCHEMBL2915999 0.81 CSF1R (0.58) CSF1RKITCYP3A4CYP2C19NTRK1
SCHEMBL2909905 0.81 CSF1R (0.55) CSF1RKITCYP3A4CYP2C19NTRK1
SCHEMBL2913417 0.80 KIT (0.59) CSF1RKITCYP3A4CYP2C19NTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951234-A2 METHOD OF INHIBITING FLT3 KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2008-08-06 EP disclosed
WO-2007048088-A2 METHOD OF INHIBITING FLT3 KINASE JANSSEN PHARMACEUTICA N.V. (BE) 2007-04-26 WO disclosed